HLA A24 Associated Tumor Immunity in HER2/neu Positive Breast Cancer

Journal Title: RECENT ADVANCES IN PATHOLOGY AND LABORATORY MEDICINE - Year 2017, Vol 3, Issue 2

Abstract

Breast carcinoma is the most common tumor in women and it has resulted in significant morbidity and mortality. Recognition of tumor-associated antigens (TAA) by HLA class I-restricted CD8+ T cells is fundamental for the detection and destruction of malignant cells. HLA A24 has been shown to be associated with presenting peptides in breast carcinoma, which can be targeted for cancer immunotherapy. Overexpression of the HER2 receptor tyrosine kinase is associated with more advanced-stage disease at presentation and a rapidly progressive clinical course. Here we present a case of a 57-year-old female, who presented with a left breast lump. On histopathological examination, diagnosis of infiltrating ductal carcinoma was made . The patient had ER, PR negative and HER/neu positive cancer with nodal metastasis to supraclavicular lymph nodes. Course of Antracycline-based chemotherapy was started. Patient showed no signs of recurrence till the time of writing the article

Authors and Affiliations

Dr. Ravi Pratap Singh

Keywords

Related Articles

Entamoeba Histolytica Infesting Colonic Malignancy: First Series of Four Cases

Entamoeba histolytica infections of the gastrointestinal tract are common in the developing world. Only two isolated cases of colonic amoebiasis with colon carcinoma have been described in literature. Here, we describe u...

Histomorphological Spectrum of Head and Neck Lesions: A Three Year Retrospective Analysis

Background: Lesions of head and neck are common in patients of all age groups. Head and neck cancers including thyroid lesions are the third commonest malignancy seen in both sexes across the globe. Aim: To study the his...

Thyroid FNAC Reporting Post-Bethesda - Problems and Challenges Faced in Our Center - A Preliminary Study

Aims and Objectives: The Bethesda system for reporting thyroid cytopathology (TBSRTC) was proposed to standardize the reporting of thyroid cytopathology for more effective clinical communication and patient management. T...

A Study to Correlate Endometrial Hyperplasia with Ovarian Stromal Change

Background: Endometrial hyperplasia in peri-menopausal age group is frequently encountered as a result of unopposed excess estrogen action, exact source of which is still debatable. Possible source is ovarian stroma. The...

Incidence of Co-infection of Malaria and Typhoid and their Diagnostic Dilemmas

Background: This study was carried out to know the incidence of co-existence of typhoid and malaria in western part of Uttar Pradesh. Both these infections are common febrile illnesses prevalent in tropical countries inc...

Download PDF file
  • EP ID EP215564
  • DOI 10.24321/2454.8642.201702
  • Views 98
  • Downloads 0

How To Cite

Dr. Ravi Pratap Singh (2017). HLA A24 Associated Tumor Immunity in HER2/neu Positive Breast Cancer. RECENT ADVANCES IN PATHOLOGY AND LABORATORY MEDICINE, 3(2), 13-16. https://europub.co.uk/articles/-A-215564